ISO 11135 is the international standard that specifies requirements for the development, validation, and routine control of an ethylene oxide (EO) sterilization process for medical devices. It defines how manufacturers demonstrate that an EO cycle reliably achieves a target sterility assurance level (SAL), most commonly 10^-6, for terminally sterilized products.
What is ISO 11135?
ISO 11135 is the recognized international standard governing ethylene oxide (EO) sterilization of health care products, including most heat-sensitive and moisture-sensitive medical devices. EO is a gas that sterilizes at low temperatures, making it suitable for plastics, electronics, and assembled devices that cannot withstand steam (moist heat) or radiation.
The standard sits in the manufacturing and quality stage of the device lifecycle, after design transfer and before routine production release. It defines the full path from process development through validation to ongoing routine control, so every sterilized batch carries documented evidence of effectiveness. Sterility cannot be confirmed by inspecting a finished device, so ISO 11135 builds confidence through a validated process rather than end-product testing.
Why ISO 11135 matters in medical device development
A device labeled sterile that is not actually sterile can cause infection, so regulators treat sterilization validation as a high-risk activity. FDA recognizes ISO 11135 as a consensus standard, and the EU MDR 2017/745 (Annex I) requires that sterile devices be manufactured and sterilized using validated methods. A weak or undocumented EO process is a common audit finding and a frequent reason for shipment holds, recalls, and warning letters.
The stakes are also commercial. EO residuals left on a device after sterilization can be toxic, so limits are controlled under ISO 10993-7. Getting validation wrong means re-running expensive cycles, delaying market entry, or re-sterilizing inventory. With EO capacity constrained across the industry, a defensible and efficient process has real value to the schedule.
How the ISO 11135 process works
ISO 11135 organizes EO sterilization into defined stages, each with documented acceptance criteria.
Process definition.
Specify the cycle parameters: preconditioning, EO gas concentration, chamber temperature, relative humidity, exposure (dwell) time, and aeration to remove residual gas.
Bioburden assessment.
Determine the number and resistance of microorganisms on the product using methods from ISO 11737-1, since the cycle must overcome the actual contamination load.
Installation and operational qualification (IQ/OQ).
Confirm the sterilizer is installed correctly and performs within specification across its operating range.
Performance qualification (PQ).
Run microbiological PQ using biological indicators (BIs), typically Bacillus atrophaeus spores, plus physical PQ to confirm temperature, humidity, and EO delivery are reproducible.
Routine control and release.
Monitor each production cycle against the validated parameters and release the product based on the defined criteria.
Most manufacturers use the overkill (half-cycle) approach, which proves full spore kill at half the routine exposure time to demonstrate a large safety margin. The target is usually a sterility assurance level (SAL) of 10^-6, meaning no more than a one-in-a-million probability of a viable organism on a sterilized unit. The standard works alongside ISO 11607 for sterile barrier packaging, ISO 14971 for risk management, and ISO 13485 for the underlying quality system.
Common challenges and best practices
The most frequent mistake is treating validation as a one-time event. Product changes, packaging changes, new suppliers, and load configuration changes can each invalidate prior validation, so a change-control link to the sterilization process is essential.
Bioburden drift is another common gap. Bioburden should be monitored on a defined schedule, not assumed to be stable, because a rising contamination load can erode the safety margin on which the validation depended.
Teams also underestimate aeration and residuals. EO and its byproducts (such as ethylene chlorohydrin) must be aerated to within the ISO 10993-7 limits before release, and rushing this step poses patient-safety and regulatory risks. Good practice is to design the device and its packaging for EO compatibility early, deliberately choose a worst-case load and product master, and keep validation records audit-ready. When devices share characteristics, a product-family grouping strategy can reduce the need for repeated validations without weakening the rationale.
Frequently asked questions
ISO 11135 is used to develop, validate, and routinely control ethylene oxide (EO) sterilization of medical devices. It applies to products that cannot tolerate steam or radiation, such as many plastics and electronics. The standard provides manufacturers with a documented basis for claiming that a device is sterile to a defined sterility assurance level.
Both cover terminal sterilization but address different methods. ISO 11135 specifies ethylene oxide (EO) sterilization, a low-temperature chemical process. ISO 11137 covers radiation sterilization (gamma, electron beam, and X-ray). The choice depends on material compatibility, device design, and the validated cycle or dose the product can support.
ISO 11135 does not specify a single value, but medical devices labeled sterile typically target a sterility assurance level (SAL) of 10^-6. That means a probability of no more than 1 viable microorganism per 1 million sterilized units. The validated cycle must demonstrate that this level is achieved.
Revalidation is driven by change and by periodic review. A documented requalification is generally performed on a defined schedule, and additional revalidation is triggered by changes to the device, packaging, load configuration, bioburden, or sterilizer. The validation rationale should state the conditions under which it is required.
ISO 11135 controls the sterilization process, but EO residual limits on finished devices are set by ISO 10993-7. After sterilization, devices must aerate until residual ethylene oxide and ethylene chlorohydrin fall within allowable limits for the contact type and duration. Verifying residuals is part of ensuring the release of a safe, sterile product.
Related terms
ISO 11607 (Sterile Barrier Packaging)
ISO 10993 (Biological Evaluation)
Biocompatibility Testing
Process Validation (IQ/OQ/PQ)
Bioburden Testing
